MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. It offers the ExPert platform based on its flow electroporation technology, which facilitates the complex engineering of cells. The company also develops the CARMA platform that enables the manufacturing of chimeric antigen receptor (CAR) therapies for a range of cancer indications.